株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

ペット用アニマルヘルスの世界市場:市場分析・シェア・動向・規模・予測

Companion Animal Health Market, By Animal Type (Equine, Dogs, Sheep & Goats, Cats, and Poultry), By Product, By Drug, By Distribution Channel, By Application and Geography - Analysis, Share, Trends, Size, & Forecast From 2014 - 2025

発行 AnalystView Market Insights 商品コード 737916
出版日 ページ情報 英文 125 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=109.52円で換算しております。
Back to Top
ペット用アニマルヘルスの世界市場:市場分析・シェア・動向・規模・予測 Companion Animal Health Market, By Animal Type (Equine, Dogs, Sheep & Goats, Cats, and Poultry), By Product, By Drug, By Distribution Channel, By Application and Geography - Analysis, Share, Trends, Size, & Forecast From 2014 - 2025
出版日: 2018年08月03日 ページ情報: 英文 125 Pages
概要

当レポートでは、世界のペット用アニマルヘルス (動物衛生) の関連市場について分析し、市場の定義や基本構造、主な市場促進・抑制要因、業界の競争力・求心力、市場シェア構造、動物の種類別・製品別・薬剤別・流通チャネル別・用途別・地域別の市場動向見通し (過去4年間・今後8年間分)、主要企業のプロファイルなどについて調査しております。

第1章 ペット用アニマルヘルス市場:概要

第2章 エグゼクティブ・サマリー

第3章 ペット用アニマルヘルス市場:主な動向

  • 市場促進要因
    • 促進要因の影響度
  • 市場抑制要因
    • 抑制要因の影響度
  • 市場機会
  • 市場の将来動向

第4章 ペット用アニマルヘルス産業の分析

  • ポーターのファイブフォース分析
  • 市場求心力の分析
  • 規制体制の分析

第5章 ペット用アニマルヘルスの市場環境

  • 市場シェア分析

第6章 ペット用アニマルヘルス市場:動物の種類別

  • 概要
  • ウマ
    • 概要
    • 市場規模の分析・予測、年間成長率 (金額ベース、通算12年間分)
  • イヌ
  • ヒツジ・ヤギ
  • ネコ
  • 鳥類

第7章 ペット用アニマルヘルス市場:製品別

  • 概要
  • ワクチン
  • 医薬品
  • 飼料添加物
  • 診断薬
  • その他

第8章 ペット用アニマルヘルス市場:薬剤の種類別

  • 概要
  • OTC (市販薬)
  • 処方薬

第9章 ペット用アニマルヘルス市場:流通チャネル別

  • 概要
  • eコマース
  • 小売店舗
  • 病院

第10章 ペット用アニマルヘルス市場:用途別

  • 概要
  • クリニック
  • PoC (ポイントオブケア) 施設
  • その他

第11章 ペット用アニマルヘルス市場:地域別

  • イントロダクション
  • 北米 (米国、カナダ)
    • 概要
    • 市場規模の分析・予測、年間成長率 (金額ベース、通算12年間分)
    • 国別分析
  • 欧州 (フランス、ドイツなど)
  • アジア太平洋地域 (中国、インドなど)
  • 他の国々 (RoW:ラテンアメリカ、中東・アフリカ)

第12章 主要ベンダーの分析

  • Merck
    • 企業概要
    • SWOT分析
    • 近年の主な動向
  • Nutreco
  • Zoetis
  • Boehringer Ingelheim
  • Bayer AG
  • Virbac

第13章 アナリストの全方位的分析

第14章 付録

図表

List of Tables

  • Table 1 List of Acronyms
  • Table 2 Key Market Facts, 2014 - 2025
  • Table 3 Market Drivers: Impact Analysis
  • Table 4 Market Restraint: Impact Analysis
  • Table 5 Market Opportunity: Impact Analysis
  • Table 6 PEST Analysis
  • Table 7 Porter's Five Forces Analysis
  • Table 8 Company Market Share Analysis
  • Table 9 Global Companion Animal Health Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
  • Table 10 Companion Animal Health Market, by Animal Type, 2014 - 2025 (USD Million)
  • Table 11 Companion Animal Health Market, by Product, 2014 - 2025 (USD Million)
  • Table 12 Companion Animal Health Market, by Drug, 2014 - 2025 (USD Million)
  • Table 13 Companion Animal Health Market, by Distribution Channel, 2014 - 2025 (USD Million)
  • Table 14 Companion Animal Health Market, by Application, 2014 - 2025 (USD Million)
  • Table 15 Companion Animal Health Market, by Geography, 2014 - 2025 (USD Million)
  • Table 16 North America Companion Animal Health Market, 2014 - 2025 (USD Million)
  • Table 17 U.S. Companion Animal Health Market, 2014 - 2025 (USD Million)
  • Table 18 Canada Companion Animal Health Market, 2014 - 2025 (USD Million)
  • Table 19 Europe Companion Animal Health Market, 2014 - 2025 (USD Million)
  • Table 20 France Companion Animal Health Market, 2014 - 2025 (USD Million)
  • Table 21 Germany Companion Animal Health Market, 2014 - 2025 (USD Million)
  • Table 22 Asia Pacific Companion Animal Health Market, 2014 - 2025 (USD Million)
  • Table 23 China Companion Animal Health Market, 2014 - 2025 (USD Million)
  • Table 24 India Companion Animal Health Market, 2014 - 2025 (USD Million)
  • Table 25 Latin America Companion Animal Health Market, 2014 - 2025 (USD Million)
  • Table 26 MEA Companion Animal Health Market, 2014 - 2025 (USD Million)

List of Figures

  • Figure 1 Research Methodology
  • Figure 2 Research Process Flow Chart
  • Figure 3 Comparative Analysis, by Geography, 2016-2025 (Value %)
  • Figure 4 Regulatory Framework Analysis
  • Figure 5 Value Chain Analysis Analysis
  • Figure 6 Companion Animal Health Market, by Animal Type, 2014 - 2025 (USD Million)
  • Figure 7 Companion Animal Health Market, by Product, 2014 - 2025 (USD Million)
  • Figure 8 Companion Animal Health Market, by Drug, 2014 - 2025 (USD Million)
  • Figure 8 Companion Animal Health Market, by Distribution Channel, 2014 - 2025 (USD Million)
  • Figure 8 Companion Animal Health Market, by Application, 2014 - 2025 (USD Million)
  • Figure 9 Companion Animal Health Market, by Geography, 2014 - 2025 (USD Million)
目次
Product Code: AV160

Report Hightlights

The companion animal health market is estimated to represent a global market of USD 12,506 million by 2017 with growth rate of 4.8%.

Market Dynamics

Companion animal health industry includes all products and services (i.e. pet services, diagnostics and OTC health) for dogs, horses, cats, and others. The growth of this industry is majorly influenced by the strong increase in the rate of pet ownership. Further, rising strategic collaborations of companies with veterinary organizations to promote awareness and improve animal health augment the market growth significantly. For instance, in 2015, Ceva partnered with the America Association of Feline Practitioners, aimed to encourage pet owner to standardize animal research and surgery practices.

Over the past few years, research and development activities in the veterinary industry have increased and thus the spending on companion animal health. According to American Pet Product Association (APPA), companion animal spending has been consistently on the rise. The organization stated that in 2011, the spending on pet industry was around USD 51 billion and is expected to reach USD 69.36 billion by 2017. The statistics from APPA also stated that around 20.0% of this spending was found to be on over-the-counter products and food & supplies, whereas 25.0% was on veterinary care, including pharmaceuticals.

In May 2015, the Federal Trade Commission (FTC) also stated that the market for veterinary medicine has shown significant growth in recent years. The organization estimated that prescription and over the counter medicine for the dogs and cats are projected to increase with a significant growth rate over the future period. All such facts indicate the rise in adoption of companion animal therapeutics thus, augment the market growth.

Furthermore, the emergence of veterinary information systems and implementation of it into fields such as consultant systems for diagnostic assistance, drug information systems, diagnostic decision assistance, and teaching tools has further aided in the growth of the market. On the flip side, increasing influx of sub-standard therapeutics in veterinary industry is considered to be the major growth restricting factors. Additionally, an absence of streamlining of national regulatory processes will hamper the industry growth to some extent.

Animal Type Takeaway

Animal type segment is categorized as Equine, Dogs, Sheep & Goats, Cats, and Poultry. Among which, dogs accounted for the largest share of the total market, has recorded USD 4.83 billion in 2016. The demand for dog's therapeutics is relatively greater than other companion animals and the trend is likely to continue over the future period. Thus, companies are increasingly developing novel therapeutics under this segment. For instance, in May 2016, European Medicines Agency (EMA) approved Merck's Bravecto Spot-on solution to treat flea and ticks in dogs. Later, in July 2016, the company also received U.S. FDA approval for this product under name Bravecto Topical.

Product Takeaway

Product segment is divided into Vaccines, Pharmaceuticals, Feed Additives, Diagnostics, and Others. Increasing research and development activities coupled with favorable government initiatives has helped pharmaceuticals segment to be on the top spot. Drugs segment is categorized into Over the Counter (OTC) and Prescription. Whereas, distribution channel segment is bifurcated into E-commerce, Retail, and Hospitals. The application segment is divided in terms of Clinics, Point-of-Care Facilities, and others.

Regional Takeaway

Regionally, North America accounted for the largest share, closely followed by Europe. Presence of a large number of established pharmaceutical companies that are consistently striving for extensive commercialization of their veterinary products is presumed to be a key factor responsible for growth in both regions. Asia Pacific region is projected to grow with the highest CAGR owing to the rise in adoption of companion animals coupled with the increasing disposable income.

Key Vendor Takeaway

Companies namely Merck, Nutreco, Zoetis, Boehringer Ingelheim, Bayer AG, and Virbac are profiled in detail. Among which, the most notable market participants are Nutreco, Bayer, and Zoetis, accounting for the majority of the revenue share. Key players operating in this market are majorly involved in the development of new products and strategic expansion of their geographic reach. For example, Zoetis offers products such as Cerenia, Convenia, Synulox, Dexdomitor, Cerenia, Palladia, and Rimadyl under companion animal therapeutics. Recently, in December 2016, US FDA approved company's first monoclonal antibody product named "CYTOPOINT". This drug act by neutralizing interleukin-31 (IL-31) and provide long-lasting relief from atopic dermatitis in dogs.

The market size and forecast for each segment and sub-segments has been considered as below:

Historical Year - 2014 & 2016

Base Year - 2017

Estimated Year - 2018

Projected Year - 2025

TARGET AUDIENCE

Traders, Distributors, and Suppliers

Manufacturers

Hospitals

Government and Regional Agencies and Research Organizations

Consultants

Distributors

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

MARKET, BY ANIMAL TYPE

Equine

Dogs

Sheep & Goats

Cats

Poultry

MARKET, BY PRODUCT

Vaccines

Pharmaceuticals

Feed Additives

Diagnostics

Others

MARKET, BY DRUG

OTC

Prescription

MARKET, BY DISTRIBUTION CHANNEL

E-commerce

Retail

Hospitals

MARKET, BY APPLICATION

Clinics

Point-of-Care Facilities

Others

MARKET, BY REGION

North America

U.S.

Canada

Europe

Germany

France

Rest of Europe

Asia Pacific

India

China

Rest of APAC

Rest of the World

Middle East and Africa

Latin America

TABLE OF CONTENTS

1. COMPANION ANIMAL HEALTH MARKET OVERVIEW

  • 1.1. Study Scope
  • 1.2. Base Year
  • 1.3. Assumption and Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Key Market Facts
  • 2.2. Geographical Scenario
  • 2.3. Companies in the Market

3. COMPANION ANIMAL HEALTH KEY MARKET TRENDS

  • 3.1. Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Future Trends

4. COMPANION ANIMAL HEALTH INDUSTRY STUDY

  • 4.1. Porter's Analysis
  • 4.2. Market Attractiveness Analysis
  • 4.3. Regulatory Framework Analysis

5. COMPANION ANIMAL HEALTH MARKET LANDSCAPE

  • 5.1. Market Share Analysis

6. COMPANION ANIMAL HEALTH MARKET - BY ANIMAL TYPE:

  • 6.1. Overview
  • 6.2. Equine
    • 6.2.1. Overview
    • 6.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
  • 6.3. Dogs
    • 6.3.1. Overview
    • 6.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
  • 6.4. Sheep & Goats
    • 6.4.1. Overview
    • 6.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
  • 6.5. Cats
    • 6.5.1. Overview
    • 6.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
  • 6.6. Poultry
    • 6.6.1. Overview
    • 6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)

7. COMPANION ANIMAL HEALTH MARKET - BY PRODUCT:

  • 7.1. Overview
  • 7.2. Vaccines
    • 7.2.1. Overview
    • 7.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
  • 7.3. Pharmaceuticals
    • 7.3.1. Overview
    • 7.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
  • 7.4. Feed Additives
    • 7.4.1. Overview
    • 7.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
  • 7.5. Diagnostics
    • 7.5.1. Overview
    • 7.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
  • 7.6. Others
    • 7.6.1. Overview
    • 7.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)

8. COMPANION ANIMAL HEALTH MARKET - BY DRUG:

  • 8.1. Overview
  • 8.2. OTC
    • 8.2.1. Overview
    • 8.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
  • 8.3. Prescription
    • 8.3.1. Overview
    • 8.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)

9. COMPANION ANIMAL HEALTH MARKET - BY DISTRIBUTION CHANNEL:

  • 9.1. Overview
  • 9.2. E-commerce
    • 9.2.1. Overview
    • 9.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
  • 9.3. Retail
    • 9.3.1. Overview
    • 9.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
  • 9.4. Hospitals
    • 9.4.1. Overview
    • 9.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)

10. COMPANION ANIMAL HEALTH MARKET - BY APPLICATION:

  • 10.1. Overview
  • 10.2. Clinics
    • 10.2.1. Overview
    • 10.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
  • 10.3. Point-of-Care Facilities
    • 10.3.1. Overview
    • 10.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
  • 10.4. Others
    • 10.4.1. Overview
    • 10.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)

11. COMPANION ANIMAL HEALTH MARKET- BY GEOGRAPHY

  • 11.1. Introduction
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
    • 11.2.3. U.S.
    • 11.2.3.1. Overview
    • 11.2.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
    • 11.2.4. Canada
    • 11.2.4.1. Overview
    • 11.2.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
    • 11.3.3. France
    • 11.3.3.1. Overview
    • 11.3.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
    • 11.3.4. Germany
    • 11.3.4.1. Overview
    • 11.3.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
    • 11.3.5. Rest of Europe
    • 11.3.5.1. Overview
    • 11.3.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
    • 11.4.3. China
    • 11.4.3.1. Overview
    • 11.4.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
    • 11.4.4. India
    • 11.4.4.1. Overview
    • 11.4.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
    • 11.4.5. Rest of APAC
    • 11.4.5.1. Overview
    • 11.4.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
  • 11.5. Rest of the World
    • 11.5.1. Overview
    • 11.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
    • 11.5.3. Latin America
    • 11.5.3.1. Overview
    • 11.5.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
    • 11.5.4. Middle East and Africa
    • 11.5.4.1. Overview
    • 11.5.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)

12. KEY VENDOR ANALYSIS

  • 12.1. Merck
    • 12.1.1. Company Overview
    • 12.1.2. SWOT Analysis
    • 12.1.3. Key Developments
  • 12.2. Nutreco
    • 12.2.1. Company Overview
    • 12.2.2. SWOT Analysis
    • 12.2.3. Key Developments
  • 12.3. Zoetis
    • 12.3.1. Company Overview
    • 12.3.2. SWOT Analysis
    • 12.3.3. Key Developments
  • 12.4. Boehringer Ingelheim
    • 12.4.1. Company Overview
    • 12.4.2. SWOT Analysis
    • 12.4.3. Key Developments
  • 12.5. Bayer AG
    • 12.5.1. Company Overview
    • 12.5.2. SWOT Analysis
    • 12.5.3. Key Developments
  • 12.6. Virbac
    • 12.6.1. Company Overview
    • 12.6.2. SWOT Analysis
    • 12.6.3. Key Developments

Client can request additional company profiling as per specific requirements

13. 360 DEGREE ANALYSTVIEW

14. APPENDIX

  • 14.1. Research Methodology
  • 14.2. Abbreviations
  • 14.3. Disclaimer
  • 14.4. Contact Us
Back to Top